Immunity research.

Immune system peptide research is anchored by two families on Apothify. Thymic peptides (Thymosin Alpha-1, Thymopentin, Thymogen, Imunofan, and the Khavinson Thymalin) are studied in T cell maturation and immune modulation research. Antimicrobial peptides (LL-37, Lactoferrin, KPV) are studied in innate immune research. The catalog also covers a small number of phagocyte research and innate defense reference compounds (Chonluten, Ovagen).

The thymic peptide family is the older of the two in research terms. Thymosin Alpha-1 has been studied in published literature since the 1970s and remains one of the most cited research immunomodulators. It appears as a prescription medicine (Zadaxin or thymalfasin) in regulated markets in over 35 countries, which is why Apothify catalogs it as encyclopedia coverage only. Thymopentin and Imunofan are synthetic compounds derived from longer thymic precursor proteins and are studied in similar experimental setups.

Antimicrobial peptide research is more recent in published volume but has produced extensive in vitro literature. LL-37 (the active fragment of human cathelicidin) and Lactoferrin (an iron binding glycoprotein with antimicrobial activity) are both studied across bacterial, fungal, and viral research models. KPV is a smaller tripeptide derived from alpha MSH and is studied across both inflammation research and antimicrobial activity in the same experiments.

Immunity research often pairs with both Healing and Recovery (because barrier function and immune signaling overlap) and Longevity (because immune aging is its own subfield). The Compare tool surfaces those cross category pairings. Researchers comparing two thymic peptides should also read the Khavinson series guide in the Learn library to understand how the lineages relate.